Session Information
Clinical Nutrition Week 10
Click here to go to the previous page
PARENTERAL NUTRITION ASSOCIATED LIVER DISEASE (PNALD): MULTIMODAL OPTIONS FOR EARLY DETECTION, PREVENTION, AND TREATMENT
Track
:
Feburary 10, 2010
Program Code:
W21
SPEAKER
(S):
Neha Parekh, MS, RD, LD, CNSD
John K. DiBaise, MD, FACG, Professor of Medicine, Division of Gastroenterology and Hepatology, Mayo Clinic, Scottsdale, AZ
Cristiano Quintini, MD, quintic@ccf.org
Kathleen Gura, PharmD, BCNSP, FASHP, Pharmacist, Division of Gastroenterology and Nutrition, Children’s Hospital Boston, Boston, MA
Description
"Clinicians commonly use routine biochemical tests to identify
parenteral nutrition dependent patients at risk for PNALD. Recent
literature suggests that this practice is unreliable and the use of newer
non-invasive techniques should be explored for early detection of
liver fibrosis in parenteral nutrition dependent patients. This cuttingedge
session will review the pathogenesis and incidence of PNALD
and will provide practicing clinicians with the newest evidence to
support changes in clinical methods of diagnosing, preventing and
treating liver disease in PN dependent patients."
parenteral nutrition dependent patients at risk for PNALD. Recent
literature suggests that this practice is unreliable and the use of newer
non-invasive techniques should be explored for early detection of
liver fibrosis in parenteral nutrition dependent patients. This cuttingedge
session will review the pathogenesis and incidence of PNALD
and will provide practicing clinicians with the newest evidence to
support changes in clinical methods of diagnosing, preventing and
treating liver disease in PN dependent patients."
Handout Online
(Code: W21)
This session is a part of:
Audio (MP3) download
(Code: W21)
This session is a part of:
